Evidence map›Paper›PMID 36354553›Full record

ArticleBioengineering (Basel, Switzerland)2022

Holistic Design of Experiments Using an Integrated Process Model.

Thomas Oberleitner, Thomas Zahel, Barbara Pretzner, Christoph Herwig

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Lifecycle DoE-The Companion for a Holistic Development Process.Bioengineering (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thomas OberleitnerCompetence Center CHASE GmbH, Ghegastraße 3, Top 3.2, 1030 Vienna, Austria.ORCID 0000-0002-1684-5150
Thomas ZahelKörber Pharma Austria GmbH, PAS-X Savvy, Mariahilferstraße 88A/1/9, 1070 Vienna, Austria.
Barbara PretznerKörber Pharma Austria GmbH, PAS-X Savvy, Mariahilferstraße 88A/1/9, 1070 Vienna, Austria.ORCID 0000-0001-9780-1848
Christoph HerwigKörber Pharma Austria GmbH, PAS-X Savvy, Mariahilferstraße 88A/1/9, 1070 Vienna, Austria.ORCID 0000-0003-2314-1458

Funding

Austrian Research Promotion Agency 844608
6 · The paper itself

Abstract

Statistical experimental designs such as factorial, optimal, or definitive screening designs represent the state of the art in biopharmaceutical process characterization. However, such methods alone do not leverage the fact that processes operate as a mutual interplay of multiple steps. Instead, they aim to investigate only one process step at a time. Here, we want to develop a new experimental design method that seeks to gain information about final product quality, placing the right type of run at the right unit operation. This is done by minimizing the simulated out-of-specification rate of an integrated process model comprised of a chain of regression models that map process parameters to critical quality attributes for each unit operation. Unit operation models are connected by passing their response to the next unit operation model as a load parameter, as is done in real-world manufacturing processes. The proposed holistic DoE (hDoE) method is benchmarked against standard process characterization approaches in a set of in silico simulation studies where data are generated by different ground truth processes to illustrate the validity over a range of scenarios. Results show that the hDoE approach leads to a >50% decrease in experiments, even for simple cases, and, at the same time, achieves the main goal of process development, validation, and manufacturing to consistently deliver product quality.

Indexed as

biopharmaceutical process validationdesign of experimentsholistic experimental designintegrated process modeloptimal designsprocess characterization

Identifiers

PMID36354553
PMCPMC9687958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.